Page 37 - Icahn Mount News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program, called SARS-CoV-2 Assessment of Viral Evolution (SAVE) and described in a paper published March 31 in Nature, assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vacci...

Program employs a coordinated approach and serves as a template for response against rapidly evolving pandemic pathogens

A team of clinical investigators at the Icahn School of Medicine at Mount Sinai has announced the launch of a Phase 1, open-label, placebo-controlled study to e

A team of clinical investigators at the Icahn School of Medicine at Mount Sinai has announced the launch of a Phase 1, open-label, placebo-controlled study to evaluate the safety and immunogenicity of an egg-based COVID-19 vaccine in healthy, vaccinated adults who have never been infected with COVID-19.

Get latest articles and stories on Science at LatestLY. For decades, a small group of medical researchers have been studying a biochemical, DNA tagging system, which switches genes on or off. Many have studied it in bacteria and now some have seen signs of it in, plants, flies, and even human brain tumours. According to a new study by researchers at the Icahn School of Medicine, there may be a hitch: much of the evidence of presence of the DNA tagging system, in higher organisms may be due to bacterial contamination, which was difficult to spot using current experimental methods. Science News ...